Association of the Q121 variant of ENPP1 gene with decreased kidney function among patients with type 2 diabetes.

Association of the Q121 variant of ENPP1 gene with decreased kidney function among patients with type 2 diabetes.
复制标题

DOI:
10.1053/j.ajkd.2008.07.040
复制
发表时间:
2009-02
期刊:
American journal of kidney diseases : the official journal of the National Kidney Foundation
影响因子:
--
通讯作者:
Trischitta V
Trischitta V
中科院分区:
其他
文献类型:
--
作者:
De Cosmo S;Minenna A;Zhang YY;Thompson R;Miscio G;Vedovato M;Rauseo A;Saller A;Mastroianno S;Pellegrini F;Trevisan R;Fioretto P;Doria A;Trischitta V

文献摘要

参考文献

被引文献

相似文献

Insulin resistance plays a role in diabetic kidney complications. The ectonucleotide pyrophosphatase/phosphodiesterase (ENPP1) (rs1044498) K121Q polymorphism has been associated with insulin resistance and related vascular complications among patients with type 2 diabetes (T2D), in many although not all studies. This study investigated whether the ENPP1 Q121 variant modulates the risk of reduced GFR in T2D. Cross-sectional study. Two Diabetes Units from Italy (Gargano e Padua) and one from the US (Boston) recruited a total of 1392 patients with T2D. The ENPP1 Q121 variant. Estimated glomerular filtration rate (eGFR) from serum creatinine, urinary albumin excretion, blood pressure, HbA1c, Triglycerides, Total cholesterol, HDL-Cholesterol Reduced GFR levels (i.e. eGFR <60 ml/min/1.73m2). In the Gargano and Boston populations, according to dominant model of inheritance, Q121 carriers (i.e. individual with either KQ or QQ genotype) had an increased risk of reduced GFR: ORs=1.69 (95%CI 1.1–2.6) and 1.50 (95%CI 1.0–2.2), respectively. In the Padua set the association was in the same direction but didn’t reach a formal statistical significance (OR=1.77, 95%CI 0.7–4.5). When the three studies were pooled, Q121 carriers showed and increased risk of reduced GFR (OR=1.58, 95%CI 1.2–2.1, p=0.002). Also pooled mean differences of absolute GFR values were different across genotype groups with Q121 carriers showing lower GFR, as compared to KK individuals (p=0.04). p values not approaching a genome-wide level of significance. Our data suggest that patients with T2D carrying the ENPP1 Q121 variant are at increased risk of reduced GFR.
DOI: 10.1210/jc.2006-0540
发表时间: 2006-12-01
影响因子: 5.8
作者:
Boettcher, Yvonne;Koerner, Antje;Kovacs, Peter
通讯作者: Kovacs, Peter
DOI: 10.2337/db06-0946
发表时间: 2007-02-01
期刊: DIABETES
影响因子: 7.7
作者:
Boonyasrisawat, Watip;Eberle, Delphine;Doria, Alessandro
通讯作者: Doria, Alessandro
DOI: 10.2337/diacare.26.2.464
发表时间: 2003-02-01
期刊: DIABETES CARE
影响因子: 16.2
作者:
Kubaszek, A;Pihlajamäki, J;Laakso, M
通讯作者: Laakso, M
DOI: 10.2337/diabetes.49.9.1601
发表时间: 2000-09-01
期刊: DIABETES
影响因子: 7.7
作者:
Gu, HF;Almgren, P;Groop, LC
通讯作者: Groop, LC
DOI: 10.1002/sim.918
发表时间: 2001-08-15
影响因子: 2
作者:
Higgins, JPT;Whitehead, A;Thompson, SG
通讯作者: Thompson, SG